Trial
NCT04296578
Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
—
Condition
Prostate Cancer
Intervention
Abiraterone Acetate
Why stopped
Study did not start
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-12